You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Direct thrombin inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

In Vitro Correction of Thrombin Generation by Concizumab for

Recruiting
  • Hemophilia
  • thrombin generation measurement
  • Saint-Etienne, France
    CHU Saint-Etienne
Dec 13, 2022

STEMI - ST Elevation Myocardial Infarction Trial (Bivalirudin, Heparin)

Unknown status
  • STEMI - ST Elevation Myocardial Infarction
  • (no location specified)
Dec 6, 2019

Anticoagulation in Patients on ECMO for Severe Lung Failure

Completed
  • ARDS
  • COVID-19
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Sep 18, 2023

Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)

Not yet recruiting
  • Coagulation Disorder
  • (no location specified)
Jul 14, 2022

Heart Failure, Volume Overload Trial in New Haven (Direct Sodium Removal Infusate 2.0)

Recruiting
  • Heart Failure
  • Volume Overload
  • Direct Sodium Removal Infusate 2.0
  • New Haven, Connecticut
    Yale University
Jul 25, 2023

Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
    • Alton, Illinois
    • +6 more
    May 18, 2022

    Atrial Fibrillation Trial in United States (Drug (Direct thrombin or Factor Xa inhibitor))

    Terminated
    Has Results
    • Atrial Fibrillation
    • Drug (Direct thrombin or Factor Xa inhibitor)
    • Los Angeles, California
    • +9 more
    Aug 11, 2020

    Haemodialysis Trial (Heparin)

    Not yet recruiting
    • Haemodialysis
    • (no location specified)
    Nov 3, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +4 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022

    Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,

    Not yet recruiting
    • Percutaneous Coronary Intervention (PCI)
    • +3 more
    • P2Y12 inhibitor
    • +2 more
    • Hasselt, Belgium
    • +13 more
    Jul 25, 2023

    Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

    Completed
    Has Results
    • Hypertension
    • COVID-19
    • Angiotensin converting enzyme inhibitor
    • +2 more
    • Kiev, Please Select, Ukraine
      Medical Practice Prof D.Ivanov
    Feb 16, 2022

    DOAC in Chinese Patients With Atrial Fibrillation

    Recruiting
    • Atrial Fibrillation
    • +6 more
    • Blood Tests
    • Hong Kong, Hong Kong
      Chinese University of Hong Kong
    Oct 11, 2022

    SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)

    Recruiting
    • SCAD
    • AMI
    • Sao Paulo, Brazil
      Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
    Nov 4, 2021

    Exploratory Drug Interaction Study Between SMIs and DOACs

    Recruiting
    • Solid Tumor
    • Cancer, Lung
      • Nijmegen, Gelderland, Netherlands
      • +1 more
      Feb 7, 2023

      Atrial Fibrillation, Venous Thromboembolism Trial in Hamilton (RABEprazole 20 Mg Oral Delayed Release Tablet, APO-Dabigatran

      Completed
      • Atrial Fibrillation
      • Venous Thromboembolism
      • RABEprazole 20 Mg Oral Delayed Release Tablet
      • APO-Dabigatran 150mg
      • Hamilton, Ontario, Canada
        The Population Health Research Institute
      Mar 18, 2022

      Urin-based Point-of-Care Testing for Direct Oral Anticoagulants

      Recruiting
      • Stroke
      • Urin-based test by the DOASENSE Dipstick Device
      • Gießen, Hesse, Germany
        Department of Neurology, University Hospital Giessen
      Sep 13, 2023

      Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)

      Active, not recruiting
      • Coronary Microvascular Dysfunction
      • Beijing, Beijing, China
        Peking university first hospital
      Aug 1, 2023

      Covid19, SARS-CoV Infection Trial in Seattle (Zinc Picolinate, Resveratrol, Zinc Picolinate Placebo)

      Terminated
      • Covid19
      • SARS-CoV Infection
      • Zinc Picolinate
      • +3 more
      • Seattle, Washington
        Swedish Medical Center
      Jul 26, 2022

      End Stage Renal Disease, Thrombosis Trial in Orlando (AB002 Dose 1, AB002 Dose 2, )

      Completed
      Has Results
      • End Stage Renal Disease
      • Thrombosis
      • AB002 Dose 1
      • +2 more
      • Orlando, Florida
        Orlando Clinical Research Center
      Apr 27, 2022

      Hemorrhagic and Ischemic Events in Post-angioplasty in

      Recruiting
      • Atrial Fibrillation
      • +3 more
      • Blood panel
      • Nîmes, France
        CHU de Nîmes
      Jan 2, 2023

      Acute Coronary Syndrome Trial in Muncie (MT1002 for Injection)

      Recruiting
      • Acute Coronary Syndrome
      • MT1002 for Injection
      • Muncie, Indiana
        Bruce Graham
      Jan 23, 2023

      Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

      Not yet recruiting
      • Liver Cirrhosis
      • Apixaban 5 MG [Eliquis]
      • Edoxaban 60 MG [Lixiana]
      • (no location specified)
      May 19, 2023

      Hypothermia and Acidosis on Coagulation During Treatment With

      Recruiting
      • Trauma
      • +3 more
      • Rivaroxaban 15 MG
      • Lund, Skåne, Sweden
        Skåne University Hospital
      Dec 30, 2022

      Atrial Fibrillation Trial in United States

      Active, not recruiting
      • Atrial Fibrillation
        • Baltimore, Maryland
        • +3 more
        Oct 29, 2021

        Bleeding Trial in Worldwide (Andexanet)

        Completed
        Has Results
        • Bleeding
        • Andexanet
        • Long Beach, California
        • +86 more
        Jan 25, 2022